Clinical characteristics of patients
| Patient | Age/sex | Type of torticollis | Disease duration (y) | Treatment duration (months) | Total dose of BTX-A in MU (treatments) |
|---|---|---|---|---|---|
| 1 | 27/F | rot, lat, ret | 10 | 83 | 6200 (10) |
| 21-150 | 40/M | rot, lat, ant | 10 | 84 | 19800 (25) |
| 3 | 63/F | rot, ret | 18 | 36 | 10100 (14) |
| 4 | 51/F | rot | 7 | 51 | 8500 (13) |
| 5 | 51/M | rot | 19 | 52 | 12300 (18) |
BTX-A = botulinum toxin type A; MU = mouse units; rot = rotation, lat = lateral flexion, ret = retrocollis; ant = anterocollis.
↵1-150 All except patient 2 had participated in the previous study of BTX-F.4